ID

17870

Descripción

Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00323557

Link

https://clinicaltrials.gov/show/NCT00323557

Palabras clave

  1. 6/10/16 6/10/16 -
Subido en

6 de octubre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Leukemia NCT00323557

Eligibility Leukemia NCT00323557

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00323557
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
1) patients in complete / partial remission or those with active chronic lymphocytic leukemia (cll) with rai stage 0 to 4.
Descripción

In complete remission | partial response | Chronic Lymphocytic Leukemia | Rai Staging System

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0677874
UMLS CUI [2]
C1521726
UMLS CUI [3]
C0023434
UMLS CUI [4]
C1514715
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients will not be entered while neutropenic (pmns < 500 cells/mm3) or having received rituximab within 6 months.
Descripción

Neutropenia | Polymorphonuclear leukocyte count | rituximab

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027947
UMLS CUI [2]
C1271714
UMLS CUI [3]
C0393022
2. patients will not be entered while febrile (temperature > 38 degrees c) within 1 week.
Descripción

Fever | Body temperature measurement degrees Celsius

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0015967
UMLS CUI [2,1]
C0886414
UMLS CUI [2,2]
C0439237
3. active infection.
Descripción

Communicable Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
4. patients with known human immunodeficiency virus (hiv) infection.
Descripción

HIV Infection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019693
5. known history of allergy to granulocyte/ macrophage colony stimulating factor (gm-csf) or pneumococcal vaccine.
Descripción

Hypersensitivity Granulocyte-Macrophage Colony-Stimulating Factor | Hypersensitivity Pneumococcal vaccine

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0079460
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0358314
6. chemotherapy other than campath, fludarabine, cyclophosphamide, in 4 weeks.
Descripción

Chemotherapy | Campath | fludarabine | Cyclophosphamide

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0939276
UMLS CUI [3]
C0059985
UMLS CUI [4]
C0010583
7. patients who have previously received pneumococcal vaccine within the preceding 12 months.
Descripción

Pneumococcal vaccine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0358314
8. absolute lymphocyte count less than 500 cells/mm3.
Descripción

Absolute lymphocyte count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3544087

Similar models

Eligibility Leukemia NCT00323557

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00323557
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
In complete remission | partial response | Chronic Lymphocytic Leukemia | Rai Staging System
Item
1) patients in complete / partial remission or those with active chronic lymphocytic leukemia (cll) with rai stage 0 to 4.
boolean
C0677874 (UMLS CUI [1])
C1521726 (UMLS CUI [2])
C0023434 (UMLS CUI [3])
C1514715 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
Neutropenia | Polymorphonuclear leukocyte count | rituximab
Item
1. patients will not be entered while neutropenic (pmns < 500 cells/mm3) or having received rituximab within 6 months.
boolean
C0027947 (UMLS CUI [1])
C1271714 (UMLS CUI [2])
C0393022 (UMLS CUI [3])
Fever | Body temperature measurement degrees Celsius
Item
2. patients will not be entered while febrile (temperature > 38 degrees c) within 1 week.
boolean
C0015967 (UMLS CUI [1])
C0886414 (UMLS CUI [2,1])
C0439237 (UMLS CUI [2,2])
Communicable Disease
Item
3. active infection.
boolean
C0009450 (UMLS CUI [1])
HIV Infection
Item
4. patients with known human immunodeficiency virus (hiv) infection.
boolean
C0019693 (UMLS CUI [1])
Hypersensitivity Granulocyte-Macrophage Colony-Stimulating Factor | Hypersensitivity Pneumococcal vaccine
Item
5. known history of allergy to granulocyte/ macrophage colony stimulating factor (gm-csf) or pneumococcal vaccine.
boolean
C0020517 (UMLS CUI [1,1])
C0079460 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0358314 (UMLS CUI [2,2])
Chemotherapy | Campath | fludarabine | Cyclophosphamide
Item
6. chemotherapy other than campath, fludarabine, cyclophosphamide, in 4 weeks.
boolean
C0392920 (UMLS CUI [1])
C0939276 (UMLS CUI [2])
C0059985 (UMLS CUI [3])
C0010583 (UMLS CUI [4])
Pneumococcal vaccine
Item
7. patients who have previously received pneumococcal vaccine within the preceding 12 months.
boolean
C0358314 (UMLS CUI [1])
Absolute lymphocyte count
Item
8. absolute lymphocyte count less than 500 cells/mm3.
boolean
C3544087 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial